Background illustration for clinical trials search

Paid Clinical Trials New York City

Discover 4,034 paid clinical trials in New York City, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

for
Lymphoma, Follicular Lymphoma, Lymphoma,Non-Hodgkin,
Location: New York NY, Boston MA, Stanford CA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 18+

Code: NCT06510361

Phase2, Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

for
B-cell Acute Lymphoblastic Leukemia
Location: Hackensack NJ, New Haven CT, Wilmington DE, Boston MA,
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Sex: All

Age: 1 - 25

Code: NCT03509961

Phase2, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: New York NY, Mineola NY, Paramus NJ, Westbury NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

Informatics Framework for Pulmonary Rehabilitation

for
COPD
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT03981783

Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: New York NY, Staten Island NY, Hackensack NJ,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: New York NY, Teaneck NJ, Mineola NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase3, Recruiting

Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease.

for
Lumbar Disc Disease
Location: New York NY
Sponsor: New York Presbyterian Hospital

Sex: All

Age: 18+

Code: NCT05146583

Recruiting

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

for
Glioma
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05489783

Recruiting

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

for
Wilms Tumor, Rhabdoid Tumor,
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT05985161

Phase2, Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

for
Cancer, Melanoma Stage III, Melanoma Stage IV,
Location: New York NY, Morristown NJ, Pittsburgh PA, Canton OH,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05970497

Phase1, Phase2, Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

for
Germ Cell Tumor
Location: New York NY, Baltimore MD, Boston MA, Columbus OH,
Sponsor: University of Sydney

Sex: All

Age: 11 - 50

Code: NCT02582697

Phase3, Recruiting

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

for
Prostate Cancer
Location: New York NY, Lake Success NY, Kingston, Richmond VA,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06235697

Phase3, Recruiting

Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA

for
Spinal Muscular Atrophy
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 12+

Code: NCT06955897

Recruiting

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

for
High-Risk Prostate Cancer
Location: The Bronx NY, Charleston SC, St Louis MO, Seattle WA,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT05593497

Phase2, Recruiting

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Hackensack NJ, Lake Success NY, Charlotte NC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06697197

Phase1, Phase2, Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for
Renal Cell Carcinoma
Location: New York NY, Mineola NY, Pittsburgh PA, Durham NC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07049926

Phase1, Phase2, Recruiting

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

for
Rectal Cancer
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70+

Code: NCT05024097

Phase2, Recruiting

Hematology Biobank: In Vitro Study of Blood Disorders

for
Hematological Disorders
Location: The Bronx NY
Sponsor: Albert Einstein College of Medicine

Sex: All

Age: 12+

Code: NCT02442011

Recruiting

ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study

for
Suspected CSF Shunt Obstruction
Location: Stony Brook NY, Philadelphia PA, Wilmington DE,
Sponsor: NeuroDx Development

Sex: All

Age: 2 - 29

Code: NCT01881711

Recruiting

CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study

for
Neck Pain, Spondylosis, Spondylosis With Myelopathy,
Location: Union NJ, Albany NY, Williamsville NY, Cleveland OH
Sponsor: ReVivo Medical, Corp.

Sex: All

Age: 22 - 70+

Code: NCT04883411

Recruiting

New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.

Why choose New York City for clinical trials?

New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.

By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.

Common conditions studied in New York City

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New York City